Applied BioCode Corporation (TPE:6598)

Applied BioCode Statistics

Total Valuation

Applied BioCode has a market cap or net worth of TWD 2.41 billion. The enterprise value is 1.86 billion.

Market Cap	2.41B
Enterprise Value	1.86B

Important Dates

The next estimated earnings date is Sunday, March 15, 2026.

Earnings Date	Mar 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Applied BioCode has 102.81 million shares outstanding. The number of shares has increased by 20.48% in one year.

Current Share Class	102.81M
Shares Outstanding	102.81M
Shares Change (YoY)	+20.48%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	10.29%
Owned by Institutions (%)	6.92%
Float	75.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.43
PB Ratio	3.51
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.93
EV / Sales	4.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.98

Financial Position

The company has a current ratio of 7.96, with a Debt / Equity ratio of 0.09.

Current Ratio	7.96
Quick Ratio	6.36
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.27
Interest Coverage	-217.38

Financial Efficiency

Return on equity (ROE) is -25.87% and return on invested capital (ROIC) is -16.85%.

Return on Equity (ROE)	-25.87%
Return on Assets (ROA)	-12.51%
Return on Invested Capital (ROIC)	-16.85%
Return on Capital Employed (ROCE)	-24.77%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.39
Inventory Turnover	1.03

Taxes

In the past 12 months, Applied BioCode has paid 25,000 in taxes.

Income Tax	25,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.70% in the last 52 weeks. The beta is 0.74, so Applied BioCode's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-2.70%
50-Day Moving Average	22.01
200-Day Moving Average	21.02
Relative Strength Index (RSI)	55.68
Average Volume (20 Days)	180,213

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Applied BioCode had revenue of TWD 443.69 million and -207.78 million in losses. Loss per share was -2.02.

Revenue	443.69M
Gross Profit	257.86M
Operating Income	-228.04M
Pretax Income	-207.76M
Net Income	-207.78M
EBITDA	-183.99M
EBIT	-228.04M
Loss Per Share	-2.02

Balance Sheet

The company has 618.16 million in cash and 62.50 million in debt, with a net cash position of 555.66 million or 5.40 per share.

Cash & Cash Equivalents	618.16M
Total Debt	62.50M
Net Cash	555.66M
Net Cash Per Share	5.40
Equity (Book Value)	687.57M
Book Value Per Share	6.69
Working Capital	767.13M

Cash Flow

In the last 12 months, operating cash flow was -225.74 million and capital expenditures -6.85 million, giving a free cash flow of -232.58 million.

Operating Cash Flow	-225.74M
Capital Expenditures	-6.85M
Free Cash Flow	-232.58M
FCF Per Share	-2.26

Margins

Gross margin is 58.12%, with operating and profit margins of -51.40% and -46.83%.

Gross Margin	58.12%
Operating Margin	-51.40%
Pretax Margin	-46.83%
Profit Margin	-46.83%
EBITDA Margin	-41.47%
EBIT Margin	-51.40%
FCF Margin	n/a

Dividends & Yields

Applied BioCode does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.48%
Shareholder Yield	-20.48%
Earnings Yield	-8.62%
FCF Yield	-9.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Applied BioCode has an Altman Z-Score of 3.85 and a Piotroski F-Score of 1.

Altman Z-Score	3.85
Piotroski F-Score	1